Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
This intro covers yearly drawdown trends for total market index funds, helping readers assess risk and anticipate potential downturns.
28,238 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Real-world assets are flowing into on-chain markets as AI-enabled DeFi trading grows. Galaxy Digital and Ondo report ...
IBM has delivered a multiyear rally, but a 2026 pullback creates a buying opportunity for patient investors. This gui...
As bitcoin oscillates, MSTY investors confront a structural risk tied to the ETF’s option strategy. The fund’s income...
In volatile markets, simplicity often wins. Here’s why I’m focusing on these only cryptocurrencies comfortable—Bitcoi...
A headline declaring Bitcoin tops $65K US-Iran sparked a relief rally, yet seasoned traders are dialing back bets. He...
Microsoft has slipped about 30% from its peak, sparking debate about whether now is the moment to buy. This guide bre...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
In 2026, Palantir and Sandisk both delivered blowout earnings, but their stock moves told different stories. This art...
Micron Technology has been a market darling, but a different S&P 500 stock has surged even more this year. This guide...
Starting with $1,000 can jumpstart a lasting investing habit. This guide shows practical ways to pick the best stocks...
Rising prices and medical bills are eroding the buying power of a standard $800k retirement. This report explains how...